Tai Chi for Osteopenic Women
This trial is active, not recruiting.
|Treatments||tai chi, standard care|
|Sponsor||Harvard University Faculty of Medicine|
|Start date||January 2008|
|End date||February 2010|
|Trial size||86 participants|
|Trial identifier||NCT01039012, R21AT003503|
This study will assess the effectiveness of Tai Chi to affect the rate of bone loss in post-menopausal women who have been diagnosed with the initial stages of bone thinning.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (outcomes assessor)|
Serum markers of bone resorption (CTX, C-terminal cross linking telopeptide of type I collagen), and bone formation (osteocalcin).
time frame: Baseline, 3 months, 9 months
Bone mass density of the lumbar spine and proximal femur (dual-energy X-ray absorptiometry).
time frame: Baseline, 9 months
Secondary outcomes include health-related quality-of-life, exercise behavior, and psychological well-being. In addition, kinetic and kinematic characterization of gait, standing, and rising from a chair are assessed in subset of participants (n=16).
time frame: Baseline, 3 months, 9 months
Female participants from 45 years up to 70 years old.
- Women ages 45-70 years
- BMD T-scores of the hip (femoral neck or trochanter) and/or spine between -1.0 and -2.5
- Post-menopausal w/out menses for ≥ 12 months
- Sedentary, i.e. do not regularly participate in physical exercise on average 1 or more times per week
- Osteoporotic (T-score < -2.5) or a fracture in the past 2 years not caused by motor vehicle accident
- Prior or current use of use of medication that increase risks of fracture (e.g. steroids, anti-convulsants, anticoagulants, lithium)
- Prior or current use of medications that modify bone metabolism (e.g. bisphosphonates, selective estrogen receptor modulators such as Raloxifene)
- Use of calcium supplements above levels suggested within the recommendations of standard care (i.e., above 1200-1500 mg)
- Current or prior year use of estrogen or calcitonin
- Malignancies other than skin cancer
- Diagnosis of anorexia along with a BMI of < 17.5
- Conditions that cause secondary osteoporosis (e.g. Cushing's syndrome, Marfan's syndrome)
- Tobacco use in past year
- Physical or mental disabilities that will preclude informed consent or active study participation
- Geographic or scheduling limitations that would preclude required participation in weekly Tai Chi classes and study procedures
- Current regular practice of Tai Chi
|Official title||Tai Chi for Osteopenic Women: A Pilot Randomized Controlled Trial|
|Description||Osteopenia is a serious and growing public health concern for women. Osteopenic women are at greater risk for fractures than women with normal bone mineral densities (BMD). Low BMD-related fractures are associated with significant long-term impairment, high morbidity rates and high medical costs. Optimal preventive and sustainable interventions for osteopenic women are not yet well-defined. Tai Chi, a mind-body exercise that is growing in popularity in the U.S., shows may be an effective, safe and practical intervention for women with low bone density. Preliminary studies suggest Tai Chi can reduce rates of BMD decline in post-menopausal women. While suggestive, these studies have numerous design limitations. We propose a pilot randomized controlled trial to assess the efficacy and feasibility of Tai Chi as an adjunct to standard care for post-menopausal osteopenic women. Eight-six osteopenic women ages 45-70 will be recruited from a large multi-specialty group practice. Our primary aim is to assess the feasibility for recruiting and retaining osteopenic women into a randomized controlled trial of 9 months of Tai Chi. Our secondary aim is to collect preliminary data on the efficacy of Tai Chi in reducing rates of bone loss in osteopenic women using sensitive markers of bone turnover and dual-energy x-ray absorptiometry. The results of this study will inform the design of a future trial evaluating the benefits and safety for Tai Chi for osteopenic women, as well as the physiological and biomechanical mechanisms through which Tai Chi may impact BMD and fracture risks associated with osteopenia.|
Call for more information